Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 6.13% vs 9.13% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 17.00% vs 3.31% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "261.40",
          "val2": "246.30",
          "chgp": "6.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.20",
          "val2": "57.60",
          "chgp": "-4.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "3.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.10",
          "val2": "4.70",
          "chgp": "-165.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47.50",
          "val2": "40.60",
          "chgp": "17.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "211.10%",
          "val2": "177.70%",
          "chgp": "3.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.79% vs 4.91% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 43.73% vs -26.79% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "937.40",
          "val2": "877.80",
          "chgp": "6.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "236.20",
          "val2": "214.20",
          "chgp": "10.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "13.20",
          "chgp": "3.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.90",
          "val2": "-42.30",
          "chgp": "113.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "173.20",
          "val2": "120.50",
          "chgp": "43.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "193.90%",
          "val2": "185.70%",
          "chgp": "0.82%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

261.40

246.30

6.13%

Operating Profit (PBDIT) excl Other Income

55.20

57.60

-4.17%

Interest

3.40

3.40

Exceptional Items

-3.10

4.70

-165.96%

Consolidate Net Profit

47.50

40.60

17.00%

Operating Profit Margin (Excl OI)

211.10%

177.70%

3.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.13% vs 9.13% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 17.00% vs 3.31% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

937.40

877.80

6.79%

Operating Profit (PBDIT) excl Other Income

236.20

214.20

10.27%

Interest

13.60

13.20

3.03%

Exceptional Items

5.90

-42.30

113.95%

Consolidate Net Profit

173.20

120.50

43.73%

Operating Profit Margin (Excl OI)

193.90%

185.70%

0.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.79% vs 4.91% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 43.73% vs -26.79% in Dec 2024

All Annual Results